Farthing C - Search Results

1

Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection.

Ho DD, Cao Y, Zhu T, Farthing C, Wang N, Gu G, Schooley RT, Daar ES. Ho DD, et al. Among authors: farthing c. N Engl J Med. 1993 Feb 11;328(6):380-5. doi: 10.1056/NEJM199302113280602. N Engl J Med. 1993. PMID: 8093634 Free article.

2

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Koup RA, et al. Among authors: farthing c. J Virol. 1994 Jul;68(7):4650-5. doi: 10.1128/JVI.68.7.4650-4655.1994. J Virol. 1994. PMID: 8207839 Free PMC article.

3

HIV-1 drug resistance in newly infected individuals.

Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, Parkin N, Markowitz M. Boden D, et al. Among authors: farthing c. JAMA. 1999 Sep 22-29;282(12):1135-41. doi: 10.1001/jama.282.12.1135. JAMA. 1999. PMID: 10501116

4

Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

Cameron DW, Japour AJ, Xu Y, Hsu A, Mellors J, Farthing C, Cohen C, Poretz D, Markowitz M, Follansbee S, Angel JB, McMahon D, Ho D, Devanarayan V, Rode R, Salgo M, Kempf DJ, Granneman R, Leonard JM, Sun E. Cameron DW, et al. Among authors: farthing c. AIDS. 1999 Feb 4;13(2):213-24. doi: 10.1097/00002030-199902040-00009. AIDS. 1999. PMID: 10202827 Clinical Trial.

5

Human immunodeficiency virus infection: a survey with special emphasis on mucocutaneous manifestations.

Friedman-Kien AE, Farthing C. Friedman-Kien AE, et al. Among authors: farthing c. Semin Dermatol. 1990 Jun;9(2):167-77. Semin Dermatol. 1990. PMID: 2202413 Review.

6

AIDS: a historical overview.

Farthing C. Farthing C. Dermatol Clin. 1991 Jul;9(3):391-6. Dermatol Clin. 1991. PMID: 1873919

7

Early virologic failure in a pilot study evaluating the efficacy of therapy containing once-daily abacavir, lamivudine, and tenofovir DF in treatment-naive HIV-infected patients.

Khanlou H, Yeh V, Guyer B, Farthing C. Khanlou H, et al. Among authors: farthing c. AIDS Patient Care STDS. 2005 Mar;19(3):135-40. doi: 10.1089/apc.2005.19.135. AIDS Patient Care STDS. 2005. PMID: 15798380

8

Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.

Wheat LJ, Farthing C, Cohen C, Pierone G, Lalezari J, Pilson RS, Siemon-Hryczyk P; TIDBID (NR15520/M61018) study team. Wheat LJ, et al. Among authors: farthing c. Antivir Ther. 2002 Sep;7(3):199-209. Antivir Ther. 2002. PMID: 12487388 Clinical Trial.

9

Drug interaction between amprenavir and lopinavir/ritonavir in salvage therapy.

Khanlou H, Graham E, Brill M, Farthing C. Khanlou H, et al. Among authors: farthing c. AIDS. 2002 Mar 29;16(5):797-8. doi: 10.1097/00002030-200203290-00018. AIDS. 2002. PMID: 11964539 No abstract available.

10

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.

Clotet B, Bellos N, Molina JM, Cooper D, Goffard JC, Lazzarin A, Wöhrmann A, Katlama C, Wilkin T, Haubrich R, Cohen C, Farthing C, Jayaweera D, Markowitz M, Ruane P, Spinosa-Guzman S, Lefebvre E; POWER 1 and 2 study groups. Clotet B, et al. Among authors: farthing c. Lancet. 2007 Apr 7;369(9568):1169-78. doi: 10.1016/S0140-6736(07)60497-8. Lancet. 2007. PMID: 17416261 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page